Cynara scolymus (artichoke), Silybum marianum (milk thistle) and Cochlospermum angolensis (borututu) are three plants widely used regarding hepatoprotective effects but to the best of our knowledge no anti-hepatocellular carcinoma activity has been studied in the most consumed forms: infusions and dietary supplements. Herein, antioxidant properties, anti-hepatocellular carcinoma activity and toxicity of infusions and dietary supplements of the mentioned plants were evaluated and compared. All the samples revealed antioxidant properties with EC 50 values lower than the daily recommended dose, but infusions showed higher biological activity than dietary supplements.
Introduction
Artichoke (Cynara scolymus L.) is an herbaceous perennial plant native to the Mediterranean Basin that belongs to the Asteraceae family (Bianco, 2005) . Consumed raw, boiled, steamed or fried, this plant is today widely cultivated all over the world for its large fleshy immature inflorescences, called heads or capitula, with edible leaves (bracts) and receptacle. Artichoke is known since ancient times as a tasty plant that can be used in soups, stews and salads, being perceived as a nutritious and healthy vegetable (Lattanzio et al., 2009) due to its antioxidant and hepatoprotective effects (Gebhardt and Fausel, 1997; Zapolska-Downar et al., 2002; Jimène-Escrig et al., 2003; Wang et al., 2003; Falleh et al., 2008; Kukić et al., 2008; Gouveia and Castilho, 2012) . This plant contains very little fat and high levels of minerals, vitamin C, fibre, inulin, polyphenols hydoxycinnamates and flavones, but most of its activity could be related to the polyphenolic fraction, mainly composed of mono-and dicaffeoylquinic acids and flavonoids (Schütz et al., 2004; Falleh et al., 2008; Lutz et al., 2011; Pandino et al., 2011; Gouveia and Castilho, 2012) .
Milk thistle (Silybum marianum (L.) Gaertn) is also a member of Asteraceae family. It's an annual to biennial herbaceous plant, native to the Mediterranean countries with reported effects against hepatotoxicity and acute and chronic liver diseases, due to its main pharmacological active ingredient silymarin (standard mixture of flavonoligans) (Giese, 2001; Zuber et al., 2002; Doehmer et al., 2011) . Beyond the hepatoprotective activity, this flavonoid complex also has antioxidant properties which seem to be related to liver damage prevention (Nencini et al., 2007; Shaker et al., 2010) . Silibinin, the major active constituent of silymarin, has been reported as inhibitor of tumour growth in hepatocarcinoma cell (Brandon-Warner et al., 2010) and animal (Bousserouel et al., 2012 ) models.
Borututu (Cochlospermum angolensis Welw.) is a widespread tree in Angola that belongs to the Cochlospermaceae family. Its bark infusion is used in the traditional medicine of Angola for the treatment of hepatic diseases and for the prophylaxis of malaria (Poppendieck, 1981; Presber et al., 1991; Silva et al., 2011) . Phenolic composition of borututu hydromethanolic and aqueous extracts were recently characterized and revealed to be rich in methyl ellagic acid and ellagic acid, respectively (Ferreres et al., 2013) . The infusion of its dry roots also showed high 2,2-diphenyl-1-picrylhydrazyl (DPPH) scavenging activity (Costa et al., 2012) .
Despite the described hepatoprotective effects of the three mentioned plants and a few reports on their anti-hepatocellular carcinoma activity (Miccadei et al., 2008; BrandonWarner et al., 2010) , studies with the most consumed forms (infusions and dietary supplements) are scarce. Hepatocellular carcinoma is a major health problem with more than 660,000 new cases per year worldwide, being a rapid fatal disease with a life expectancy of about 6 months from the time of diagnostics; it has the third highest mortality rate among all cancers (Jemal et al., 2011) . In the present work, infusions and dietary supplements of artichoke, milk thistle and borututu were prepared and studied for antioxidant properties, anti-hepatocellular carcinoma activity and hepatotoxicity in non-tumour liver primary cells. Furthermore, all these properties were correlated with the content in bioactive compounds. thistle and borututu were obtained from an herbalist shop in Bragança (Portugal), as dry material for infusions preparation (leaves, plant and bark, respectively; the taxonomical identification of plant species mentioned in the labels was confirmed) and dietary supplements (pills based-on plant and roots, in the case of borututu). All the samples were prepared according to the label and submitted to an evaluation of bioactive compounds (phenolics and flavonoids), antioxidant activity, anti-hepatocellular carcinoma activity and hepatotoxicity.
Material and Methods
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Infusions preparation.
A dry weight of each material (20 g of artichoke and 8.5 g of milk thistle corresponding to the recommended 4 spoons; and 10 g of borututu) was added to 1 L or 0.5 L (in the case of borututu) of boiling distilled water, left to stand at room temperature for 10 min, filtered under reduced pressure, frozen, lyophilized and redissolved in distilled water at a final concentration of 10 mg/mL. The following dilutions were used in the biological assays: 10 mg/mL to 1.22 µg/mL for antioxidant activity assays; 400, 100, 25, 6.25 and 1.56 µg/mL for hepatotoxicity assays.
Dietary supplements preparation.
Three pills of each sample (1500 mg) were dissolved in 100 mL of distilled water (final concentration 15 mg/mL). Several dilutions of each sample were prepared to perform further assays. The following dilutions were 6 used in the biological assays: 15 mg/mL to 0.23 mg/mL for antioxidant activity assays; 400, 100, 25, 6.25 and 1.56 µg/mL for hepatotoxicity assays.
Standards and reagents
2,2-Diphenyl-1-picrylhydrazyl (DPPH) was obtained from Alfa Aesar (Ward Hill, USA). Gallic acid, catechin, trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid), ellipticine, phosphate buffered saline (PBS), acetic acid, sulforhodamine B (SRB), trichloroacetic acid (TCA) and Tris were purchased from Sigma (St. Louis, USA). Foetal bovine serum (FBS), L-glutamine, Hank's balanced salt solution (HBSS), trypsin-EDTA (ethylenediaminetetraacetic acid), nonessential amino acids solution (2 mM), penicillin/streptomycin solution (100 U/mL and 100 mg/mL, respectively) and DMEM (Dulbecco's Modified Eagle Medium) were from Hyclone (Logan, USA). Water was treated in a Milli-Q water purification system (TGI Pure Water Systems, USA).
Quantification of total bioactive compounds
Total phenolics were estimated by Folin-Ciocalteu colorimetric assay according to procedures previously described (Batista et al., 2011) and the results were expressed as mg of gallic acid equivalents (GAE) per g of sample (lyophilized infusion or pill).
Total flavonoids were determined by a colorimetric assay using aluminum trichloride, following procedures previously reported (Batista et al., 2011) ; the results were expressed as mg of (+)-catechin equivalents (CE) per g of sample (lyophilized infusion or pill).
Evaluation of antioxidant activity
The antioxidant properties were evaluated by four different tests as there is no universal method that can measure the antioxidant capacity of all samples accurately and quantitatively: DPPH radical-scavenging activity, reducing power, inhibition of β-carotene bleaching and inhibition of lipid peroxidation using TBARS (thiobarbituric acid reactive substances) in brain homogenates (Rafael et al., 2011) . The results were expressed in EC 50 values (sample concentration providing 50% of antioxidant activity or 0.5 of absorbance in the reducing power assay). Trolox was used as positive control.
DPPH radical-scavenging activity.
This methodology was performed using an 
Reducing power.
The sample solutions (0.5 mL) were mixed with sodium phosphate buffer (200 mmol/L, pH 6.6, 0.5 mL) and potassium ferricyanide (1% w/v, 0.5 mL). The mixture was incubated at 50 °C for 20 min, and trichloroacetic acid (10% w/v, 0.5 mL) was added. The mixture (0.8 mL) was poured in the 48 wells plate, the same with deionised water (0.8 mL) and ferric chloride (0.1% w/v, 0.16 mL), and the absorbance was measured at 690 nm in the Microplate Reader mentioned above.
Inhibition of β-carotene bleaching.
A solution of β-carotene was prepared by dissolving β-carotene (2 mg) in chloroform (10 mL). Two milliliters of this solution were pipetted into a round-bottom flask. The chloroform was removed at 40 °C under vacuum and linoleic acid (40 mg), Tween 80 emulsifier (400 mg), and distilled water (100 mL) were added to the flask with vigorous shaking. Aliquots (4.8 mL) of this emulsion were transferred into test tubes containing sample solutions (0.2 mL). The tubes were shaken and incubated at 50 °C in a water bath. As soon as the emulsion was added to each tube, the zero time absorbance was measured at 470 nm. β-Carotene bleaching inhibition was measured by the formula: β-carotene absorbance after 2h/initial absorbance) × 100. 
TBARS assay. Porcine (Sus
Evaluation of hepatocellular carcinoma activity
The anti-hepatocellular carcinoma activity was evaluated using HepG2, which is the most widely used tumour cell line and generally regarded as a good hepatocellular carcinoma model. HepG2 cells were routinely maintained as adherent cell cultures in DMEM supplemented with 10% FBS, 2 mM glutamine, 100 U/mL penicillin and 100 mg/mL streptomycin, at 37 ºC, in a humidified air incubator containing 5% CO 2 . The cell line was plated at 1.0 × 10 4 cells/well in 96-well plates. Cells were then treated for 48h with the sample solutions. Following this incubation period, the adherent cells were fixed by adding cold 10% trichloroacetic acid (TCA, 100 µL) and incubated for 60 min at 4 ºC. Plates were then washed with deionized water and dried; sulforhodamine B solution (0.1% in 1% acetic acid, 100 µL) was added to each plate well and incubated for 30 min at room temperature. Unbound SRB was removed by washing with 1% acetic acid. Plates were air dried, the bound SRB was solubilised with 10 mM Tris (200 µL, pH 7.4) and the absorbance was measured at 540 nm (Guimarães et al., 2013) in the microplate reader mentioned above. The results were expressed in GI 50 values (sample concentration that inhibited 50% of the net cell growth). Ellipticine was used as positive control.
Evaluation of hepatotoxicity
The hepatotoxicity was accessed using a non-tumour liver primary culture established in our laboratory (PLP2). The cell culture was prepared from a freshly harvested porcine liver obtained from a local slaughter house. Once in the lab, the liver tissues were rinsed in Hank's balanced salt solution containing 100 U/mL penicillin, 100 µg/mL streptomycin and divided into 1×1 mm 3 explants. Five explants were placed in 25 cm 2 tissue flasks in DMEM medium supplemented with 10% FBS, 2 mM nonessential amino acids and 100 U/mL penicillin, 100 mg/mL streptomycin and incubated at 37 ºC with a humidified atmosphere containing 5% CO 2 . The medium was changed every two days. Cultivation of the cells was continued with direct monitoring every two to three days using a phase contrast microscope. Before confluence, cells were subcultured and plated in 96-well plates at a density of 1.0×10 4 cells/well, and cultivated in DMEM medium with 10% FBS, 100 U/mL penicillin and 100 µg/mL streptomycin (Guimarães et al., 2013) . Cells were treated for 48h with the sample solutions and the same procedure described in the previous section for SRB assay was followed. The results were expressed in GI 50 values (sample concentration that inhibited 50% of the net cell growth). Ellipticine was used as positive control.
Statistical analysis
For all the experiments three samples (n=3) were analysed and all the assays were carried out in triplicate. The results are expressed as mean values and standard deviation (SD). The differences between the different samples were analyzed using one-way analysis of variance (ANOVA) followed by Tukey's honestly significant difference post hoc test with α = 0.05, coupled with Welch's statistic. This treatment was carried out using SPSS v. 18.0 program. The regression analysis between total phenolic or flavonoid contents, and antioxidant activity EC 50 values and anti-hepatocellular carcinoma activity GI 50 values used the same statistical package.
Results and Discussion
Bioactive compounds, antioxidant activity and hepatotoxicity of the infusions
The results for infusions and dietary supplements are present in Tables 1 and 2, respectively. Borututu infusion gave the highest amounts of total phenolics and flavonoids, as also the highest antioxidant activity in all the assays ( Table 1) . The infusions of milk thistle and artichoke revealed, in general, similar contents in phenolics and antioxidant activity. The much higher content of total phenolics (132.26 mg GAE/g) and flavonoids (17.88 mg CE/g) observed in borututu infusion might be related to the part of the plant used in this case (bark).
Although there are some reports on phenolics, flavonoids and DPPH scavenging activity of artichoke (Jimènez-Escrig et al., 2003; Falleh et al., 2008; Kubić et al., 2008; Lutz et al., 2011; Gouveia and Castilho, 2012) , the studies were performed in extracts and not in the real forms of consumption (e.g. infusions and dietary supplements as herein). Nevertheless, it should be highlighted that most of the mentioned solvents present toxicity and do not mimetize the most consumed forms as previously stated.
Costa et al. (2012) also described phenolics, flavonoids and DPPH scavenging activity in borututu infusion (1.4 mg GAE/100 mL, 0.34 mg epicatechin equivalents/100 mL and DPPH EC 50 =1.9 mg trolox equivalents/100 mL).
In the present work, artichoke and borututu infusions demonstrated anti-hepatocellular carcinoma activity with GI 50 values of 52 and 146 µg/mL, respectively, but artichoke showed toxicity in normal cells (72 µg/mL). Despite the lower activity of borututu infusion, this sample did not show any hepatotoxicity in normal cells (GI 50 > 400 µg/mL); milk thistle also did not reveal toxicity in normal liver cells ( Table 1) .
As can be observed in Table 3 , the bioactive properties (antioxidant and antitumour) of the infusions were positively correlated (p<0.05) with phenolics and flavonoids content.
Bioactive compounds, antioxidant activity and hepatotoxicity of the dietary supplements
Regarding dietary supplements, the amount of bioactive compounds and the degree of antioxidant activity was as follows: borututu > milk thistle > artichoke. These samples neither revealed anti-hepatocelullar carcinoma activity (HepG2 GI 50 value>400 µg/mL), nor toxicity for normal liver cells (PLP2 GI 50 value>400 µg/mL) ( Table 2 ).
The biological activity of the dietary supplements was positively correlated (p<0.05) with the total phenolics and flavonoids content (Table 3) Table 2 . Bioactive compounds, antioxidant activity and hepatotoxicity of the dietary supplements.
* Trolox and ellipticine for antioxidant and hepatotoxicity assays, respectively. EC 50 values correspond to the sample concentration achieving 50% of antioxidant activity or 0.5 of absorbance in reducing power assay. GI 50 values correspond to the sample concentration achieving 50% of growth inhibition in HepG2 human hepatocellular carcinoma cell line or in liver primary culture PLP2. n.p.-not possible to determine. In each row different letters mean significant differences (p<0.05). 
